2024
DNA methylation in long COVID
Xiao Y, Vermund S. DNA methylation in long COVID. Frontiers In Virology 2024, 4: 1371683. DOI: 10.3389/fviro.2024.1371683.Peer-Reviewed Original ResearchDNA methylationSevere acute respiratory syndromeAcute coronavirus disease 2019Middle East respiratory syndromeLong-term sequelaeDNA methylation phenomenonLong COVIDPredictive of outcomeCombination of clinical signsAcute COVID-19DNA methylation markersVirus-host interactionsLong lasting persistenceSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Respiratory syndromeChronic symptomsEpigenetic phenomenaSyndrome coronavirus 2Evolving syndromeCoronavirus disease 2019Long COVID patientsSyndromeAcute respiratory syndrome
2023
COVID-19 vaccine equity in Africa
Turyasingura N, James W, Vermund S. COVID-19 vaccine equity in Africa. Transactions Of The Royal Society Of Tropical Medicine And Hygiene 2023, 117: 470-472. PMID: 36622662, PMCID: PMC10235805, DOI: 10.1093/trstmh/trac130.Peer-Reviewed Original ResearchConceptsVaccine equitySevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Severe COVID-19 infectionRespiratory syndrome coronavirus 2Coronavirus disease 2019 (COVID-19) pandemicSyndrome coronavirus 2COVID-19 vaccination ratesCOVID-19 infectionDisease 2019 pandemicLower COVID-19 vaccination ratesCoronavirus 2Vaccination ratesVaccine developmentVaccine distributionGlobal health discourseHealth discourseHigh-income nationsHospitalizationInfection
2022
No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination
Lu-Culligan A, Tabachnikova A, Pérez-Then E, Tokuyama M, Lee HJ, Lucas C, Monteiro V, Miric M, Brache V, Cochon L, Muenker MC, Mohanty S, Huang J, Kang I, Dela Cruz C, Farhadian S, Campbell M, Yildirim I, Shaw AC, Ma S, Vermund SH, Ko AI, Omer SB, Iwasaki A. No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination. PLOS Biology 2022, 20: e3001506. PMID: 35609110, PMCID: PMC9129011, DOI: 10.1371/journal.pbio.3001506.Peer-Reviewed Original ResearchConceptsCOVID-19 mRNA vaccinationMRNA vaccinationEarly pregnancyFetal sizeCoronavirus disease 2019 (COVID-19) mRNA vaccinationSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Maternal antibody statusAdverse neonatal outcomesSyndrome coronavirus 2Birth defectsPolyinosinic-polycytidylic acidCrown-rump lengthGross birth defectsUnvaccinated adultsMaternal illnessNeonatal outcomesVaccinated adultsAntibody statusTLR3 agonistEarly immunizationMurine pregnancyAntibody inductionCoronavirus 2